Intellectual property laws like patents can also pose regulatory barriers. Patents grant exclusive rights to pharmaceutical companies to produce and sell a new drug, often leading to high prices. While patents incentivize innovation, they can also delay the introduction of generic drugs, which are usually more affordable.